{"url_path":"/sec/arct/8-k/2026-07-02/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 **","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-02","source_url":"https://www.sec.gov/Archives/edgar/data/1768224/0001193805-26-000910-index.html","accession_number":"0001193805-26-000910","cik":"0001768224","ticker":"ARCT","issuer_name":"Arcturus Therapeutics Holdings Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1768224/0001193805-26-000910-index.html","primary_entity_key":"0001768224","primary_entity_name":"Arcturus Therapeutics Holdings Inc."},"word_count":82,"has_tables":true,"body_markdown":"**Item 9.01**\n**Financial Statements and Exhibits.**\n\n \n\n**(d) Exhibits.**\n\n \n\n**Exhibit No.**\n**Description**\n\n99.1\n[Press Release dated July 2, 2026](e665618_ex99-1.htm)\n\n104\nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\n \n\n \n\n \n\n  \n\n**SIGNATURES**\n\n \n\nPursuant to the requirements\nof the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto\nduly authorized.\n\n \n\n \n**Arcturus Therapeutics Holdings Inc.**\n\nDate: July 2, 2026\n \n\n \n \n \n\n \nBy:\n\n/s/ Joseph E. Payne\n\n \nName:\nJoseph E. Payne\n\n \nTitle:\nChief Executive Officer"}